ZA201204422B - Mesalamine suppository - Google Patents

Mesalamine suppository

Info

Publication number
ZA201204422B
ZA201204422B ZA2012/04422A ZA201204422A ZA201204422B ZA 201204422 B ZA201204422 B ZA 201204422B ZA 2012/04422 A ZA2012/04422 A ZA 2012/04422A ZA 201204422 A ZA201204422 A ZA 201204422A ZA 201204422 B ZA201204422 B ZA 201204422B
Authority
ZA
South Africa
Prior art keywords
mesalamine suppository
mesalamine
suppository
Prior art date
Application number
ZA2012/04422A
Other languages
English (en)
Inventor
Yves Dumoulin
David Powell
Carl Gauthier
Hugues Moreau
Original Assignee
Aptalis Pharma Canada Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=43901620&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA201204422(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Aptalis Pharma Canada Inc filed Critical Aptalis Pharma Canada Inc
Publication of ZA201204422B publication Critical patent/ZA201204422B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/606—Salicylic acid; Derivatives thereof having amino groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0031—Rectum, anus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/136—Amines having aromatic rings, e.g. ketamine, nortriptyline having the amino group directly attached to the aromatic ring, e.g. benzeneamine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA2012/04422A 2009-12-16 2012-06-15 Mesalamine suppository ZA201204422B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12/639,645 US8436051B2 (en) 2007-06-08 2009-12-16 Mesalamine suppository
PCT/US2010/060849 WO2011084638A2 (en) 2009-12-16 2010-12-16 Mesalamine suppository

Publications (1)

Publication Number Publication Date
ZA201204422B true ZA201204422B (en) 2013-08-28

Family

ID=43901620

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA2012/04422A ZA201204422B (en) 2009-12-16 2012-06-15 Mesalamine suppository

Country Status (14)

Country Link
US (2) US8436051B2 (cg-RX-API-DMAC7.html)
EP (1) EP2512443A2 (cg-RX-API-DMAC7.html)
JP (1) JP2013514979A (cg-RX-API-DMAC7.html)
KR (1) KR20120104604A (cg-RX-API-DMAC7.html)
CN (1) CN102970971A (cg-RX-API-DMAC7.html)
AU (1) AU2010339837A1 (cg-RX-API-DMAC7.html)
CA (2) CA2690450A1 (cg-RX-API-DMAC7.html)
CL (1) CL2012001636A1 (cg-RX-API-DMAC7.html)
IL (1) IL220397A0 (cg-RX-API-DMAC7.html)
MX (1) MX2012006902A (cg-RX-API-DMAC7.html)
RU (1) RU2012125186A (cg-RX-API-DMAC7.html)
SG (1) SG181169A1 (cg-RX-API-DMAC7.html)
WO (1) WO2011084638A2 (cg-RX-API-DMAC7.html)
ZA (1) ZA201204422B (cg-RX-API-DMAC7.html)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8436051B2 (en) 2007-06-08 2013-05-07 Aptalis Pharma Canada Inc. Mesalamine suppository
PL2166128T3 (pl) 2008-09-19 2012-05-31 Oerlikon Trading Ag Sposób wytwarzania powłok z tlenków metali przez naparowywanie łukowe
EP2614045B1 (de) * 2010-09-10 2015-11-18 Pharmazell GmbH Verfahren zur herstellung kristalliner 5-aminosalicylsäure
WO2013059768A1 (en) * 2011-10-20 2013-04-25 Aptalis Pharma U.S., Inc. Therapeutic agents for treating gastrointestinal disorders associated with inflammation of the gastrointestinal tract
CN103622974B (zh) * 2013-12-05 2016-04-20 武汉武药科技有限公司 一种含美沙拉嗪和n-乙酰半胱氨酸的复方栓剂及其制备方法
US20160175271A1 (en) * 2014-12-19 2016-06-23 Gavis Pharmaceuticals Rectal suppository for ulcerative colitis
US10098898B1 (en) 2017-12-04 2018-10-16 Handa Pharmaceuticals, Llc Release stable mesalamine dosage forms
US20220378697A1 (en) * 2019-10-31 2022-12-01 R.P. Scherer Technologies, Llc Suppository capsule
KR20250042058A (ko) 2023-09-19 2025-03-26 한양대학교 산학협력단 염증성 장 질환 치료용 약학적 조성물

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3689514A (en) * 1969-05-21 1972-09-05 Schlueter Edelfett Suppository vehicle and process of making same
US4211777A (en) * 1977-11-25 1980-07-08 Fisons Limited Compositions comprising a compound having sodium cromoglycate activity and aminosalicylic acid
US4298595A (en) * 1978-12-20 1981-11-03 Dynapol Pharmaceutical preparations containing a polymeric agent for releasing 5-aminosalicylic acid or its salts into the gastrointestinal tract
US4374932A (en) * 1981-06-08 1983-02-22 G. D. Searle & Co. 5-ASA Drug delivery system
DE3151196A1 (de) * 1981-12-23 1983-06-30 Kurt Heinz Prof. Dr. 7800 Freiburg Bauer Verfahren zur herstellung von gut loeslichen 5-aminosalicylsaeure-arzneimittelzubereitungen
JPH0816051B2 (ja) * 1988-12-07 1996-02-21 エスエス製薬株式会社 徐放性坐剤
US5629012A (en) * 1991-06-17 1997-05-13 Farmaceutisk Laboratorium Ferring A/S Process for producing suppositories by compression and suppositories obtained by the process
GB9201857D0 (en) * 1992-01-29 1992-03-18 Smithkline Beecham Plc Novel compound
US5389375A (en) * 1993-05-21 1995-02-14 University Of Mississippi Stable suppository formulations effecting bioavailability of Δ9 -thc
DK66493D0 (da) * 1993-06-08 1993-06-08 Ferring A S Praeparater, isaer til brug ved behandling af inflammatoriske tarmsygdomme eller til at opnaa forbedret saarheling
CA2231176C (en) * 1995-09-07 2008-04-01 Taisho Pharmaceutical Co., Ltd. Long active composition for rectal administration
JPH09323934A (ja) * 1996-05-31 1997-12-16 Kanebo Ltd 保存安定性の改善された坐剤
CA2285923C (en) 1997-04-01 2013-03-12 Thomas Julius Borody Methods and compositions for treating inflammatory bowel disease
WO1999016454A1 (en) * 1997-09-26 1999-04-08 Medeva Europe Limited Pharmaceutical composition for the treatment of inflammatory bowel disease
CA2305761A1 (en) * 1997-10-08 1999-04-15 Taisho Pharmaceutical Co., Ltd. Composition for suppositories
US6326364B1 (en) * 1999-02-08 2001-12-04 Cedars-Sinai Medical Center Use of 5-aminosalicylates as antimicrobial agents
US6610674B1 (en) * 1999-09-28 2003-08-26 University Of Pennsylvania Method of treating inflammatory conditions with progesterone analogs
US6720001B2 (en) * 1999-10-18 2004-04-13 Lipocine, Inc. Emulsion compositions for polyfunctional active ingredients
US20020037855A1 (en) * 2000-05-05 2002-03-28 Fritz Stanislaus Stabilized medicament containing cysteinyl derivatives
AU2001285311B2 (en) * 2000-08-29 2005-09-15 Biocon, Ltd Immunoregulatory compounds, derivatives thereof and their use
JP2006501242A (ja) * 2002-08-23 2006-01-12 ザイモジェネティクス， インク． 炎症性腸疾患の治療方法
US7312243B1 (en) * 2003-08-29 2007-12-25 Jay Pravda Materials and methods for treatment of gastrointestinal disorders
US7825106B2 (en) * 2003-09-03 2010-11-02 Agi Therapeutics Ltd. Modified release formulations and methods of treating inflammatory bowel disease
CA2553775A1 (en) * 2004-01-20 2005-08-11 Richard F. Harty Compositions and methods of treatment for inflammatory diseases
CA2565993C (en) * 2004-05-27 2011-08-16 Antibe Therapeutics Inc. Salt of 4-or 5- aminosalicylic acid
CZ296169B6 (cs) * 2004-09-08 2006-01-11 Pliva - Lachema A. S. Farmaceutická kompozice pro rektální nebo vaginální podání, zpusob její prípravy a tato kompozice pro pouzití jako lécivo
CA2581775A1 (en) * 2004-09-27 2006-04-06 Sigmoid Biotechnologies Limited Dihydropyrimidine microcapsule - formulations
US7250445B1 (en) * 2005-01-14 2007-07-31 Ehrenpreis Eli D Anti-oxidant suppository for treating radiation proctopathy and other anorectal disorders
US8921344B2 (en) * 2006-11-03 2014-12-30 Salix Pharmaceuticals, Inc. Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives
EP1993540A4 (en) * 2006-03-07 2010-06-09 Combinatorx Inc COMPOSITIONS AND METHODS FOR THE TREATMENT OF IMMUNOINFLAMMATORY DISORDERS
EP2034816A1 (en) * 2006-04-05 2009-03-18 Oklahoma Medical Research Foundation O-glycans in the treatment of inflammatory bowel disease and cancers
EP2015639A4 (en) * 2006-05-01 2009-11-25 Napo Pharmaceuticals Inc METHOD FOR TREATING CONSTITUTIONAL PREDOMINANT IRRITATION SYNDROME
US20070254050A1 (en) * 2006-05-01 2007-11-01 Quart Barry D Method for treatment of diarrhea-predominant irritable bowel syndrome
WO2008031013A1 (en) * 2006-09-08 2008-03-13 Gene Logic Inc. Method for treating inflammatory diseases of the digestive tract
US8436051B2 (en) 2007-06-08 2013-05-07 Aptalis Pharma Canada Inc. Mesalamine suppository
US8217083B2 (en) * 2007-06-08 2012-07-10 Aptalis Pharma Canada Inc. Mesalamine suppository
US7541384B2 (en) * 2007-06-08 2009-06-02 Axcan Pharma Inc. Mesalamine suppository

Also Published As

Publication number Publication date
KR20120104604A (ko) 2012-09-21
RU2012125186A (ru) 2014-01-27
US8436051B2 (en) 2013-05-07
SG181169A1 (en) 2012-07-30
US9884018B2 (en) 2018-02-06
US20130231310A1 (en) 2013-09-05
WO2011084638A2 (en) 2011-07-14
CA2690450A1 (en) 2011-06-16
JP2013514979A (ja) 2013-05-02
US20100105639A1 (en) 2010-04-29
CN102970971A (zh) 2013-03-13
MX2012006902A (es) 2012-10-05
CA2784772A1 (en) 2011-07-14
AU2010339837A1 (en) 2012-06-28
EP2512443A2 (en) 2012-10-24
IL220397A0 (en) 2012-08-30
CL2012001636A1 (es) 2012-10-12
WO2011084638A3 (en) 2012-04-05

Similar Documents

Publication Publication Date Title
EP2515891A4 (en) 3-keto-N-propargyl-1-aminoindan
GB0905568D0 (en) Taxling
ZA201204422B (en) Mesalamine suppository
IL208602A0 (en) Mezuzah case
GB0906473D0 (en) Pro-mole
AU4240P (en) Tuckerbox xTriticosecale
GB0915153D0 (en) Rule
GB0900167D0 (en) B b
GB0905223D0 (en) Case
TWM372836U (en) Case
GB0906628D0 (en) Cigbin
GB0908303D0 (en) Fixarad
GB0900651D0 (en) Birdcatcher
GB0900893D0 (en) Cardvlope
GB0901350D0 (en) Rec-cp
GB0902438D0 (en) Corcost-t10
AP2009000321S (en) Doropak
GB0903732D0 (en) Switchcase
GB0904235D0 (en) Drydam
GB0904250D0 (en) Laptap
GB0900201D0 (en) Lasha2A
GB0904981D0 (en) Spinback
GB0903475D0 (en) livelonger
GB0907095D0 (en) BuzBars
GB0907241D0 (en) Seakite